Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × Chemoradiotherapy × Clear all

NCT03993249 2022-03-23

Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy

Phase 2 Unknown

Urinary Bladder Neoplasms